UniCredit Bonus Zert BNTX 27.06.2.../ DE000HD3TM79 /
07/06/2024 19:35:25 | Chg.-0.650 | Bid21:51:43 | Ask21:51:43 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
90.300EUR | -0.71% | 90.130 Bid Size: 400 |
90.190 Ask Size: 400 |
BioNTech SE | - USD | 27/06/2025 | Call |
GlobeNewswire
01/06
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire
29/05
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire
28/05
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire
21/05
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire
21/05
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire
17/05
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire
17/05
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire
09/05
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
02/05
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
22/04
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire
10/04
Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire
07/04
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire
28/03
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
20/03
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire
20/03
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire
14/03
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates